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Abstract
Gene delivery technologies to introduce foreign genes into highly differentiated mammalian cells have improved
significantly over the last few decades. Relatively new techniques such as magnetic nanoparticle-based gene transfection
technology are showing great promise in terms of its high transfection efficiency and wide-ranging research applications.
We have developed a novel gene delivery technique, which uses magnetic nanoparticles moving under the influence of an
oscillating magnetic array. Herein we successfully introduced short interfering RNA (siRNA) against green fluorescent protein
(GFP) or actin into stably-transfected GFP-HeLa cells or wild-type HeLa and rat aortic smooth muscle cells, respectively. This
gene silencing technique occurred in a dose- and cell density- dependent manner, as reflected using fluorescence intensity
and adhesion assays. Furthermore, using endocytosis inhibitors, we established that these magnetic nanoparticle-nucleic
acid complexes, moving across the cell surface under the influence of an oscillating magnet array, enters into the cells via
the caveolae-mediated endocytic pathway.
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Introduction
Recent decades have seen the rise of gene delivery technologies
to introduce foreign genes into highly differentiated cells like
neurons or leukocytes, as such cells are known to be resistant to
either accepting or expressing exogenous genes. Such technologies
range from the relatively inexpensive lipid-based (e.g Lipofecta-
mine) or non-lipid based (e.g. Fugene) reagents to more costly
nucleofection (e.g. Amaxa) or gene gun (e.g. Helios) methods
(reviewed in [1]). Magnetic nanoparticle-based gene transfection
technology is a relatively new and effective tool to introduce
plasmid DNA or short interfering RNA (siRNA) into mammalian
cells. Briefly, negatively-charged nucleic acids are electrostatically
associated to positively-charged, polymer-coated superparamag-
netic iron oxide nanoparticles (SPIONs). Next, these complexes
are subjected to a strong high-gradient magnet field produced by
arrays of permanent magnets sited underneath the cell culture
plate. The effect of the field gradient is to essentially pull the
particle/nucleic acid complex onto the surfaces of the cells. Our
group has found that by introducing a linear oscillating motion to
the magnet array, we can regulate the uptake of nanoparticle/
plasmid DNA complexes (Figure 1).
Although we, and others, have shown successful transfection
with this technology [2,3], even with hard-to-transfect cells types
such as mouse embryonic fibroblasts (MEF), human umbilical vein
endothelial cells (HUVEC) [4], human osteosarcoma fibroblasts
[5], primary rat oligodendrocyte precursor cells [6], purified
primary rat astrocytes [7], primary cardiomyocytes (Subramanian
et al, unpublished data) – with little negative effects on cell
viability, migration, proliferation and differentiation, the potential
of the technology is still to be further explored.
Remarkable differences were observed using human lung
epithelial cells NCI-H292 transfected with a plasmid containing
the luciferase reporter gene. A 2 Hz/0.2 mm frequency and
amplitude of displacement of the oscillating magnet array showed
higher transfection efficiency with little negative impact on cell
viability compared with a static magnet system and two
commercially available lipid-based reagents [2,3]. Nanomagnetic
transfection is also dependent on the magnet strength and its
distance from the cell surface [3].
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Here we show successful gene silencing of GFP and actin in
stably-transfected GFP-HeLa cells and wild-type HeLa cells,
respectively using this novel transfection system which outper-
formed a leading lipid reagent and a static magnet array system.
Using endocytosis inhibitors, we also confirm that the route of
entry for these nanoparticle-nucleic acid complexes is via the
caveolae-mediated endocytic pathway, a process that appears to
be enhanced by mechanical stimulation of the cells due to the
oscillatory motion of the particle complexes across the cell surface.
Methods
Materials
Silencer GFP siRNA (siGFP) and the Negative Control
(scrambled sequences, SCR) were purchased from Ambion/
Invitrogen (Paisley, UK). Stealth siRNA against human Actin
(siActin) was purchased from Invitrogen (Paisley, UK). Phosphate
buffered saline, 24-well tissue cell culture plates and flasks (Costar)
were purchased from Sigma (Dorset, UK). HeLa cells were
purchased from ECACC/Sigma (Dorset, UK). Rat Aortic Smooth
Muscle cells were a kind gift from Eva Pantazaka/Colin Taylor
(University of Cambridge) [8]. Cells were maintained in the
antibiotic-free medium consisting of high glucose MEM, 10%
Fetal Bovine Serum (FBS) and 2 mM L-glutamine, purchased
from Biosera (East Sussex, UK). Endocytosis inhibitors were
purchased from either Calbiochem/Merck (Nottingham, UK) or
Sigma (Dorset, UK).
DNA Constructs
Eukaryotic expression vector pEGFP-N1 (CMV promoter
driving gene encoding green fluorescence) was purchased from
Clontech (Mountain View, USA). Plasmid DNA was prepared
using the Qiagen EndoFree Plasmid Purification kit (Qiagen,
Crawley, UK), and maintained in endonuclease-free water (Sigma,
Dorset, UK) at 280uC.
Creation of Stably Transfected GFP-HeLa
90000 HeLa cells per well were seeded onto a 24-well tissue
culture plate and left overnight in a 37uC, 5% CO2 incubator.
0.6 mg of pEGFP-N1 (Clontech, UK) was complexed with 0.6 ml
of nTMag (nanoTherics, Stoke-On-Trent, UK) in serum-free
MEM for 15 min before transferring to the wells containing HeLa
cells. nTMag is Fe3O4 dispersed in a polyethylenimine-HCl
matrix; zeta potential: +23.4 mV; particle size distribution: 1.8
(polydisperse index). Cell were transfected using the magnefect-
nano II system (nanoTherics, UK) before transferring the 24-well
plate to the incubator for 48 hr. Fresh medium was replaced
containing 0.5 mg/ml G418 (Biosera, UK). After 14 days,
brightest GFP-expressing colonies of HeLa cells were selected
visually and transferred to a 96-well plate. Another round of
selection was conducted after a further 20 days, with cells then
transferred to a 6-well plate. Finally GFP-HeLa cells were
expanded to a 25 cm2 flask and cell sorted (Flow Cytometry Core
Service, University of Sheffield) to enrich the population of GFP-
expressing HeLa cells. Approximately 1 million GFP-HeLa cells
were frozen down (liquid nitrogen) in a mixture containing 10%
DMSO/FBS.
Transfection of Cells
Oscillating nanomagnetic transfection. 10,000/50,000
RASMC, 50,000 HeLa or 100,000 GFP-HeLa in antibiotic-free
medium were seeded in 24-well plates, incubated at 37uC, 5%
CO2, for 24 hr before addition of transfection complexes. To
prepare transfection complexes, 10–300 nM siActin or 0.1–20 nM
siGFP were diluted in 100 ml serum-free media, added to 1.2–
2.0 ml nTMag (nanoTherics, UK) and mixed. After 20 min,
complexes were added drop-wise to cells, with control wells
Figure 1. Principle of oscillating nanomagnetic transfection. Short interfering RNA (siRNA) or plasmid DNA is attached to magnetic
nanoparticles and incubated with cells in culture (left). An oscillating magnet array below the surface of the cell culture plate pulls the particles into
contact with the cell membrane (A) and drags the particles from side-to-side across the cells (B), mechanically stimulating endocytosis (C). Once the
particle/nucleic acids complex is endocytosed, proton sponge effects rupture the endosome (D) releasing the nucleic acids (E) which either
transcribes the target protein or silences the target genes (F) [3].
doi:10.1371/journal.pone.0051350.g001
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comprising untransfected cells. Plates were incubated in the
presence of an oscillating magnetic field (2 Hz at 0.2 mm
amplitude of displacement) using the magnefect-nano II (na-
noTherics, UK) system.
Lipofectamine. Cells were seeded into 24-well tissue culture
plates as described before. Lipofectamine 2000 complexes were
prepared in serum free medium using 33 nM of siRNA with 1 ml
of Lipofectamine 2000 per well following the manufacturer’s
recommended protocol. After 20 min incubation, complexes were
added drop-wise to cells, and incubated at 37uC, 5% CO2, before
analysis.
Nucleofection. Cells were transfected by nucleofection
(Amaxa/Lonza, DE) using program I-13, according to manufac-
turer’s instructions. Cells were left to express plasmids for 72 or
168 hr before flow cytometric analysis.
Flow Cytometry
Transfected cells were washed in 0.5% bovine serum albumin
and phosphate-buffered saline (PBS) and analysed for the relative
fluorescence of gated cells, using a FACSort analyser (Becton
Dickinson, USA). Median fluorescence intensity of gated cells was
determined through the FL1 channel.
Viability Assay
Cell viability was assessed using the MTT [3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide] assay, which is based
on the ability of a mitochondrial dehydrogenase enzyme from
viable cells to cleave the tetrazolium rings of the pale yellow MTT
to form dark blue formazan crystals. 0.5 mg/ml of MTT dissolved
in serum-free medium was added to cells in wells. Cells were
allowed to accumulate crystals for 2–4 hr in a 37uC, 5% CO2
incubator, before they were solubilised with dimethyl sulfoxide and
read using spectrophotometer at a wavelength of 595 nm. Number
of viable cells was directly proportional to the level of the formazan
product created [9,10].
Adhesion Assay
This protocol was based on Dormoy-Raclet et al [11]. Six-well
plates were coated with 0.1% gelatin at 4uC overnight. To avoid
nonspecific binding, wells were blocked with 1% bovine serum
albumin (BSA) for 1 hr at 37uC. Control, siRNA-transfected HeLa
cells were trypsinised and plated on the matrix-coated wells for
6 hr. Adherent cells were fixed with methanol at 220uC and
stained with Hoechst 33342 (Sigma, UK). The nuclei were
counted by fluorescence microscopy (IX71, Olympus, UK). A
minimum of three images were captured at fixed exposure settings,
and an average of the number of nuclei from cells transfected with
target siRNA was related to a scrambled control. Significance was
tested using Student’s t test. P,0.05 was considered significant and
is indicated by a single asterisk.
Treatment with Inhibitors
Cells were treated with 2–50 mg/ml chlorpromazine (CHL),
1.0–25 mg/ml filipin, 0.2–5 mM 5-(N-ethyl-N-isopropyl) amiloride
(EIPA) (Sigma, Dorset, UK), 40–1000 mM genistein (GENI) or 8–
200 mM dynasore (DYNA) (Calbiochem/Merck, Nottingham,
UK) in serum-free culture medium for 30 min at 37uC.
Subsequently, nTMag complexed with GFP in serum-free
medium were added drop-wise to cells, transfected at 2Hz with
0.2 mm amplitude of displacement using the magnefect-nano II
system (nanoTherics, UK) for 30 min, and incubated for a further
1 hr (2 hr total contact time with inhibitors). Fresh serum-
containing medium was replaced and cells were analysed for
transfection efficiency and viability using fluorescence microscopy
and the MTT assay after 24 hr, respectively. Total transfection
was obtained by multiplying the proportion of GFP transfected
cells by its corresponding %viability.
Results
Knock-down of GFP from Stably Transfected GFP-HeLa
using an Oscillating Magnet Array
We sought to transfect short interfering ribonucleic acid
(siRNA)-associated magnetic nanoparticles into mammalian cells
using the oscillating magnet array. For simplicity, and as proof of
principle, HeLa cells were first stably transfected with a plasmid
encoding green fluorescence protein (GFP), selected (G418) and
sorted on the basis of GFP as described in the Methods section.
Stably-expressing GFP-HeLa cells were transfected with siRNA
against GFP using Lipofectamine 2000, nucleofection technology
(both according to manufacturers’ recommended instructions) and
the oscillating magnet array system (Figure 2).
Gene silencing was determined using fluorescence median
within a gated population of cells and normalising to a scrambled
siRNA control. Although the nucleofection method was able to
silence GFP after 72 hr (77.760.4%) using a high dose of siRNA
(500 nM), this was not sustained as observed after 168 hr
(43.663.8%, data not shown). The oscillating magnet array
system, with a lower dose of siRNA (20 nM), showed approxi-
mately 61.166.1% knockdown of GFP, both after 72 hr and
168 hr (Figure 2 and data not shown). Cells transfected using
Lipofectamine 2000, in accordance with manufacturer’s instruc-
tions, demonstrated good gene silencing (54.866.3%), though cell
rounding was observed which correlated with reduced viability
(data not shown). These results demonstrate the ability of the
oscillating magnet array system to achieve gene knock-down in a
cell line with an over-expressed reporter gene.
Gene Silencing of Actin from HeLa and Rat Aortic
Smooth Muscle Cells
Next we wanted to silence an endogenous protein using the
oscillating magnet array technology. Actin, a major cytoskeletal
protein, found ubiquitously in eukaryotes, is known to be involved
in a range of cellular activities including adhesion [12]. Recent
work has demonstrated that transfecting 120 nM siRNA against b-
actin in HeLa cells using Lipofectamine Plus led to approximately
60% reduction of reattached HeLa cells after 72 hr, as observed
using adhesion assays, when compared to the scrambled control
siRNA [11]. We looked specifically at the gene silencing by
transfection using magnetic nanoparticles complexed with siRNA
against b-actin and the oscillating magnet array, and to determine
its effects using a physiological assay.
In HeLa cells, we were successful in introducing siRNA against
b-actin using the oscillating magnet array, as evidenced by a
decrease in reattached HeLa cells onto gelatine-coated plates
72 hr after transfection [11] (c.f. Figure 3A and 3B). This occurs in
a (siRNA) dose-dependent manner, whereas cells transfected using
Lipofectamine 2000 (with 33 nM of siRNA in accordance to the
manufacturer’s instruction) showed low reattached HeLa cells
(Figure 3C). At a higher dose of siRNA against actin (300 nM), the
effect was maintained over time (data not shown).
A similar effect can be seen in a primary cell type, the rat aortic
smooth muscle cells (Figure 3D and 3E). The actin gene was
knocked-down at varying levels, in a dose- and cell density-
dependent manner. At 10,000 cells per well, the highest knock
down of actin was using 10 nM of siRNAs (69.0611.0%, as
determined using the adhesion assay, normalised to scrambled
Entry of Magnetic Nanoparticles via Endocytosis
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control). Decreasing viability was seen with increasing dose of
complexes, suggesting some toxic effects of the complexes at
higher concentrations. Despite the very low viabilities, it must be
noted that the MTT viability assay, as a colorimetric assay, is
affected by sensitivity issues. The readout is probably an
underestimation as to the actual number of cells remaining, based
on a manual count of nuclei after transferring cells from one plate
to another.
This contrasted with wells plated with 50,000 cells, which had
more consistent levels of knock-down at all concentrations of
siRNAs and viabilities (between 39.863.0% for 1 nM to
52.667.1% for 300 nM; Figure 3D) presumably due to
‘diluting’ effect of complexes by the higher number of cells.
Unsurprisingly, transfection efficiencies also impacted cell
viabilities with transfection using 10,000 cells per well showing
a clear dose-dependent effect, whereas, transfection with 50,000
per well was better in maintaining high cell viabilities. Overall,
these results demonstrate success in delivering siRNA into HeLa
cells using magnetic nanoparticles and the accompanying
oscillating magnet array and its subsequent gene silencing
effects.
Nucleic Acid-nanoparticle Complexes Enter HeLa Cells in
a Caveolae-dependent Endocytosis
Finally, in order to understand the mechanism by which these
nucleic acid-nanoparticle complexes enter into the target cells, we
investigated the impact of endocytosis blockers on nanomagnetic
transfection efficiency. It has been reported that non-viral gene
carriers including magnetic nanoparticles, are energy dependent
and exploit the endocytic pathway to gain entry into their target
cells [13,14,15]. Hence we used varying doses of endocytosis
inhibitors such as 5-(N-ethyl-N-isopropyl) amiloride (EIPA, a
macropinocytosis blocker) [16,17], Chlorpromazine (a drug that
disrupts clathrin-mediated endocytosis) [18,19], Dynasore (a
dynamin inhibitor – dynamin promotes the formation of
clathrin-coated vesicles, a crucial stage in clathrin-mediated
endocytosis) [20,21,22], Genistein and Filipin (a tyrosine kinase
inhibitor that inhibits the caveolae-mediated endocytosis) [18,23]
to determine the pathway by which the nucleic acid-nanoparticle
complexes enter into HeLa cells. In order to assay the effect of
these blockers on transfection, we complexed nTMag with
pEGFP-N1 plasmid (which over expresses Green Fluorescent
Protein) to report on the entry of the magnetic nanoparticles.
Figure 2. Knockdown of GFP from GFP-HeLa cells. Stably-expressing GFP-HeLa cells were transfected, either with a lipid reagent, nucleofection
method or magnetofection using an oscillating magnet (2Hz frequency amplitude and 0.2 mm displacement), as indicated. Magnetofection using
nTMag only was set as negative control (Mock). Fluorescent intensity (Median) was determined 72 hr post-transfection and knockdown levels were
normalised to a scrambled control. Results are expressed as the mean6SD of at least three independent experiments. *, p,0.05; **, p$0.05.
doi:10.1371/journal.pone.0051350.g002
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On analysis 24 hrs post transfection, we found transfection of
HeLa cells with nTMag associated with pEGFP-N1 plasmid was
affected by low doses (Figure 4A, white bars) of endocytosis
inhibitors (all p,0.05) when compared to the untreated control
(Figure 4A, black bars, 49.064.5%). Unsurprisingly, cell viabilities
were minimally affected with low doses of all endocytic inhibitors.
Medium doses (optimal concentrations, based on abovementioned
publications; grey bars) of Genistein (16.566.4%) and Chlor-
promazine (18.569.3%) affected transfection efficiencies, with
little effect on cell viabilities (Figure 4B,C). Filipin completely
inhibited transfection of HeLa cells with some decrease in cell
viability (32.765.0%, p,0.05 c.f. no inhibitor control) while
transfection efficiencies remained virtually unchanged for Dyna-
sore and EIPA. High doses (hatched bars) of EIPA, Chlorprom-
azine and Filipin decreased both transfection efficiencies and cell
viabilities. High doses of Dynasore demonstrated a modest
decrease in transfection efficiency (21.960.5%), though it did
not inhibit viability (17.9610.3%). Interestingly, high doses of
Genistein had no effect on cell viability, although it reduced
transfection efficiency dramatically (6.760.3%). Therefore, we
suggest that these plasmid-associated nanoparticles enter cells via
the caveolae-mediated pathway.
Discussion
Previously we have demonstrated the use of a horizontal/lateral
motion to a magnet array improves the transfection of both easy-
and hard-to-transfect cell lines (as described earlier). In this study
we explored the potential of this technique for gene silencing using
short-interfering RNA (siRNA) and to understand the molecular
mechanism behind magnetofection using an oscillating magnet
array. As proof of principle, we created stably expressed green
fluorescence protein (GFP) in HeLa and HEK293 cells by
transfecting using our oscillating magnet array system and
selecting using G418 antibiotics. Following sorting based on
GFP fluorescence, we succeeded in silencing the GFP gene using
siRNA complexed with nTMag and transfected with our
oscillating magnet array. Our oscillating magnet array system
had the benefit of using less siRNA in order to achieve high levels
of gene silencing, compared with the nucleofection method. Also
our system appears to prolong siRNA knock-down function
without the overgrowth of untransfected cells or cell death over
time, something we observed with the nucleofection and lipid
reagent methods, respectively.
Next we examined knock-down of an endogenous gene. Actin, a
major cytoskeletal protein, found ubiquitously in eukaryotes, is
known to be involved in cell division, phago-/endo-/exo-cytosis,
motility/adhesion, etc [12,24,25,26]. Transfecting siRNA against
b-actin in HeLa cells led to a decrease in cell growth and strong
cellular blebbing [27] or a marked decrease in stress fibre
formation, cell adhesion and migration [11]. We observed a
physiological knock-down of actin in HeLa cells, in a dose-
dependent manner, as observed using the adhesion assay. Others
have successfully knocked-down various genes in HeLa cells or
Figure 3. Knockdown of Actin from HeLa and Rat Aortic Smooth Muscle Cells. HeLa (A–C) or rat aortic smooth muscle cells (D, E)
transfected with the either scrambled siRNA or siRNA against actin, as indicated, were seeded on six-well gelatine-coated plates 72 hrs post-
transfection. Adherent, Hoechst–stained (nuclear) HeLa cells after transfection with scrambled siRNA (A) or actin siRNA (B) were counted by
fluorescence microscopy, as described in the Methods section. Knockdown of actin in HeLa (C) or rat aortic smooth muscle cells (D) and its viability (E)
was expressed as a percentage of the number of adherent cells transfected by actin siRNA over its scrambled control. Data represent the mean6SD
of at least three independent experiments.
doi:10.1371/journal.pone.0051350.g003
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other cell lines using a combination of cationic liposomes and/or
magnetofection with a stationary magnet [28,29,30]. While
transfection efficiencies of siRNA between lipid methodology
and magnetofection were similar, the significant difference is one
of viability – with lipid methodology causing greater cell death
compared to magnetofection [31]. We successfully silenced actin
in primary rat aortic smooth muscle cells and demonstrated that
this occurs in a cell density- and dose- (i.e. siRNA-nanoparticle
complexes) dependent manner.
Another aim of this work was to determine route of entry of the
magnetic nanoparticle complexes into the cell. Magnetofection of
HeLa cells involves a combination of non-specific, clathrin- and
caveolae- dependent endocytosis, as determined using antimycin
A, a non-specific endocytic and other energy-dependent processes
[32] and markers specific for clathrin- (FITC-labelled transferring-
polylysine) and caveolae- (Alexa Fluor 594 cholera toxin subunit B)
mediated endocytosis [33]. More recently others have demon-
strated that in the absence of a magnet, magnetite-coated
polystyrene particles (300 nm diameter) were taken up by
astrocytes in a temperature dependent manner, suggesting the
need for energy during uptake. Blocking studies showed that
macropinocytosis (as demonstrated using amiloride and EIPA), not
caveolin-dependent endocytosis, was involved with the uptake of
such magnetic nanoparticles by astrocytes. Clathrin-dependent
endocytosis was only partially involved [13].
Previously we have shown that using our oscillating magnet
array (set to oscillate at 2Hz with a 0.2 mm displacement), NCI-
H292 cells transfected with magnetic nanoparticles associated with
a plasmid containing a luciferase reporter had 50% decrease in
luciferase expression, in the presence of either antimycin A (1 mg/
ml) or nystatin (25 mg/ml), in general agreement with [33] (data
not shown). However, antimycin A is a metabolic inhibitor and
blocks most energy-dependent processes and nystatin, a cholesterol
depleting compound which disrupts caveolae/lipid rafts and
destabilises clathrin coated pits as well [34,35] and moreover it
was shown that nystatin switches the internalization of endostatin
from caveolae/lipid rafts to clathrin-coated pits in HUVECs [36].
Therefore there is a need to ascertain the route of entry for the
magnetic nanoparticle complexes when under the influence of an
oscillating magnet array.
Using a combination of endocytosis inhibitors, we found that
magnetic nanoparticles complexed with plasmid encoding GFP,
entered HeLa cells via caveolae-mediated endocytosis. While our
results are largely in agreement with other groups [33], there are
some differences. In [33], they found that in three different cell
lines (HeLa included), magnetic nanoparticles coated with either a
fluorescently-labelled, clathrin- or caveolae- specific marker,
entered the cells via both pathways as determined using
fluorescence microscopy. This slight discrepancy could be due to
either our use of smaller nanoparticles (100 nm c.f. 200 nm in
[33]), our use of the oscillating magnet array which could favour
one pathway over the other due to mechanical stimulation of the
cells, or our use of endocytosis inhibitors for this study.
While we are aware of the pitfalls of using pharmacological
inhibitors to study the endocytic route of entry for the magnetic
nanoparticles – e.g. lack of specificity on the part of the inhibitor
itself, efficacy of inhibition and viability of cells after exposure to
inhibitors and transfection is highly cell dependent [14], we chose
endocytosis inhibitors based on current knowledge as to their
specificity and the impact they have on the pathway in question
[14]. Overall, while there is more work that needs to be
undertaken to further confirm these results, these preliminary
results indicate that using our oscillating magnet array system,
magnetic nanoparticles enter cells via a caveolae-mediated
pathway.
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